Lymphoma, Non-Hodgkin
Showing NaN - NaN of 25
Lymphoma, Non-Hodgkin Trial in Worldwide (Standard of Care, JCAR017)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Standard of Care
- JCAR017
-
Phoenix, Arizona
- +78 more
Jan 13, 2023
Lymphoma, Non-Hodgkin Trial in Germany, Puerto Rico, United States (Lenalidomide, Rituximab)
Active, not recruiting
- Lymphoma, Non-Hodgkin
-
Tucson, Arizona
- +114 more
Jan 11, 2023
Lymphoma, Non-Hodgkin, Lymphoma, Nonhodgkin, Lymphoma, B-Cell Trial in United States (lisocabtagene maraleucel)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +3 more
- lisocabtagene maraleucel
-
Gilbert, Arizona
- +40 more
Apr 22, 2022
Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)
Enrolling by invitation
- Lymphoma, B-Cell
- +4 more
-
Burbank, California
- +90 more
Mar 31, 2022
Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Lymphoma, Non-Hodgkin
- HIV Infections
- Bleomycin sulfate
- +9 more
-
Los Angeles, California
- +21 more
Oct 26, 2021
Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Lymphoma, Non-Hodgkin
- HIV Infections
- Bleomycin sulfate
- +9 more
-
Los Angeles, California
- +13 more
Oct 27, 2021
Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin Trial in United States (Autologous transplantation
Completed
- Lymphoma, B-Cell
- +2 more
- Autologous transplantation using rituxan/BEAM
- Autologous transplantation using Bexxar/BEAM
-
New Haven, Connecticut
- +35 more
Oct 21, 2021
Family Study of Lymphoproliferative Disorders
Recruiting
- Lymphoma, Non-Hodgkin
- +4 more
-
Rochester, MinnesotaMayo Clinic
Aug 30, 2021
Lymphoma Epidemiology of Outcomes Cohort Years 6-10
Enrolling by invitation
- Lymphoma, Non-Hodgkin
-
Miami, Florida
- +7 more
Aug 20, 2021
Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma
Completed
- Hodgkin Disease
- Lymphoma, Non-Hodgkin
- Survey
-
Rochester, New YorkUniversity of Rochester Medical Center
Mar 4, 2021
Lymphoma, Non-Hodgkin Trial in Worldwide (Venetoclax, Cyclophosphamide, Obinutuzumab)
Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)
Completed
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, Non-Hodgkin
- brentuximab vedotin
-
Birmingham, Alabama
- +21 more
Feb 2, 2017
Lymphoma, Non-Hodgkin Trial in United States (Fludarabine, Velcade, Rituximab)
Lymphoma, Non-Hodgkin, MALT Lymphoma Trial in Boston, Rochester (Fludarabine, Rituximab)
Completed
- Lymphoma, Non-Hodgkin
- MALT Lymphoma
-
Boston, Massachusetts
- +3 more
Jul 28, 2016
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Worldwide (SGN-40, , rituximab)
Terminated
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- SGN-40
- +5 more
-
Birmingham, Alabama
- +65 more
Feb 6, 2015
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in United States (SGN-40)
Completed
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
-
Birmingham, Alabama
- +13 more
Dec 17, 2014
Carcinoma, Renal Cell, Lymphoma, Non-Hodgkin Trial in United States (SGN-75)
Completed
- Carcinoma, Renal Cell
- Lymphoma, Non-Hodgkin
-
Birmingham, Alabama
- +8 more
Dec 17, 2014
Lymphoma, Non-Hodgkin Trial in Canada, United States (Granulocyte colony-stimulating factor plus plerixafor, Granulocyte
Completed
- Lymphoma, Non-Hodgkin
- Granulocyte colony-stimulating factor plus plerixafor
- Granulocyte colony-stimulating factor plus placebo
-
Phoenix, Arizona
- +31 more
Feb 10, 2014
Lymphoma, Non-Hodgkin, Multiple Myeloma Trial in United States (G-CSF Plus Plerixafor)
Completed
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- G-CSF Plus Plerixafor
-
Little Rock, Arkansas
- +7 more
Feb 10, 2014
Lymphoma, Non-Hodgkin, Multiple Myeloma Trial in United States (G-CSF and plerixafor)
Completed
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- G-CSF and plerixafor
-
Duarte, California
- +4 more
Feb 10, 2014
Lymphoma, Non-Hodgkin Trial in United States (TRAIL-R1 mAb (TRM-1; HGS-ETR1))
Completed
- Lymphoma, Non-Hodgkin
- TRAIL-R1 mAb (TRM-1; HGS-ETR1)
-
Rochester, Minnesota
- +6 more
Aug 1, 2013
A Study of Patients With AIDS Syndrome
Completed
- Sarcoma, Kaposi
- +3 more
-
Menlo Park, California
- +22 more
Sep 11, 2008